SuzanneBMerrillMD

PubMed

• 151 citations
  Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants
  Joshua I. Warrick, Gottfrid Sjödahl, Matthew Kaag, Jay D. Raman, Suzanne B. Merrill
  European Urology. 2019-01-01
• 1 citations
  Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology Residents.
  Kathryn A Marchetti, Charles A Ferreri, Emma C Bethel, Bori Lesser-Lee, Stephanie Daignault-Newton
  Urology. 2024-03-01
• 14 citations
  FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
  Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman
  Nature Communications. 2022-11-02

Journal Articles

• Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...  
  Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
• Oncologic Surveillance Following Radical Cystectomy: An Individualized Risk-based Approach  
  Merrill SB, Boorjian SA, Thompson RH, Psutka S, Cheville JC, Thapa P, Tollefson M, Frank I, World Journal of Urology, 1/6/2017
• Postoperative Surveillance for Renal Cell Carcinoma  
  Merrill SB, Urologic Clinics of North America, 1/1/2017
• Complications and outcomes associated with surgical management of renal cell carcinoma involving the liver: a matched cohort study  
  Joyce DD, Psutka SP, Thompson RH, Boorjian SA, Cheville JC, Stewart-Merrill SB, Lohse C, Costello BA, Que F, Leibovich BC, Urology, 1/1/2017
• Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes  
  Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH, BJU Int, 1/1/2017
• Decreased skeletal muscle mass is associated with an incrased risk of mortality following radical nephrectomy for localized renal cell cancer  
  Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Costello BA, Thompson RH, Stewart-Merrill SB, Lohse CM, Cheville JC, Leibovich BC, Tollefson MK, Journal of Urology, 1/1/2016
• Resource use in the last year of life among patients who died with versus of prostate cancer  
  Dinan MA, Li Y, Zhang Y, Stewart SB, Curtis LH, George DJ, Reed SD, Clinical Genitourinary Cancer, 1/1/2016
• Standardizing the definition for biochemical recurrence following radical prostatectomy: What PSA cut-point best reflects a durable rise and predicts systemic progres...  
  Toussi A, Stewart-Merrill SB, Boorjian SA, Psutka SP, Thompson RH, Frank I, Tollefson MK, Gettman MT, Bergstralh E, Carlson RE, Karnes RJ, Journal of Urology, 1/1/2016
• Oncologic Surveillance in Bladder Cancer Following Radical Cystectomy: A Systematic Review and Meta-Analysis  
  Stewart-Merrill SB, Alahdab F, Benkhadra K, Wang Z, Sorita A, Boorjian SA, Frank I, Murad MH, Urologic Oncology, 1/1/2016
• Concordance of pathologic features between metastatic sites and the primary tumor in surgically resected metastatic renal cell carcinoma  
  Psutka SP, Cheville JC, Costello BA, Stewart-Merrill SB, Lohse CM, Leibovich BC, Boorjian SA, Thompson RH, Urology, 1/1/2016
• Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective  
  Stewart SB, Boorjian SA, Urologic Oncology, 1/1/2015
• Mortality after radical cystectomy: The impact of obesity versus adiposity after adjusting for skeletal muscle wasting  
  Psutka SP, Boorjian SA, Moynagh MR, Schmit GD, Frank I, Carrasco A, Stewart SB, Tarrell R, Thapa P, Tollefson MK, Journal of Urology, 1/1/2015
• The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma  
  Psutka SP, Boorjian SA, Lohse CM, Stewart SB, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH, Urologic Oncology, 1/1/2015
• Oncologic Surveillance Following Surgical Resection for Renal Cell Carcinoma: A Novel Risk-based Approach  
  Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka S, Lohse CM, Cheville JC, Leibovich BC, Frank I, Journal of Clinical Oncology, 1/1/2015
• Evaluation of Current Surveillance Guidelines Following Radical Cystectomy and Proposal of a Novel Risk-based Approach  
  Stewart-Merrill SB, Boorjian SA, Thompson RH, Psutka S, Cheville JC, Thapa P, Bergstrahl EJ, Tollefson M, Frank I, Urologic Oncology, 1/1/2015
• Clinical and radiographic predictors of the need for inferior vena caval resection during nephrectomy for patients with renal cell carcinoma and caval tumor thrombus  
  Psutka SP, Boorjian SA, Thompson RH, Schmit GD, Schmitz JJ, Bower TC, Stewart SB, Lohse CM, Cheville JC, Leibovich BC, British Journal of Urology International, 1/28/2014
• Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses  
  Thompson RH, Atwell T, Schmit G, Lohse C, Kurup AN, Weisbrod A, Psutka SP, Stewart SB, Callstrom MR, Cheville JC, Boorjian SA, Leibovich BC, European Urology, 1/6/2014
• Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy  
  Stewart SB, Cheville JC, Sebo TJ, Frank I, Boorjian SA, Thompson RH, Gettman MT, Tollefson MK, Umbriet EC, Psutka SJ, Bergstralh E, Rangel L, Karnes RJ, Prostate Cancer and Prostatic Dis, 1/1/2014
• Sarcopenia is patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality  
  Psutka SP, Carrasco A, Moynagh M, Schmit G, Stewart SB, Boorjian SA, Frank I, Thapa P, Tarrell R, Tollefson MK, Cancer, 1/1/2014
• A framework to evaluate the cost-effectiveness of the NADiA ProsVue PSA slope to guide adjuvant radiotherapy among men with high-risk characteristics following prostat...  
  Reed AD, Stewart SB, Scales CD, Moul JW, Value Health, 1/1/2014
• Diabetes mellitus is independently associated with an increased risk of mortality among clear cell renal cell carcinoma patients  
  Psutka SP, Stewart SB, Boorjian SA, Lohse CM, Tollefson MK, Cheville JC, Leibovich BC, Thompson RH, Journal of Urology, 1/1/2014
• Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines  
  Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse C, Boorjian SA, Leibovich BC, Journal of Clinical Oncology, 1/1/2014
• Does the multidisciplinary approach improve oncologic outcomes in men undergoing surgical treatment for prostate cancer?  
  Stewart SB, Robertson CN, Freedland SJ, Polascik TJ, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW, Banez LL, International Journal of Urology, 1/1/2014
• Will the future of health care lead to the end of the robotic golden years?  
  Biehn Stewart S, Reed SD, Moul JW, European Urology, 1/22/2012
• Pre-treatment expectations in patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy  
  Schoreck FR, Krupski TL, Stewart SB, Banez LL, Gerber L, Albala DM, Moul JW, Journal of Urology, 1/1/2012
• Join now to see all

Books/Book Chapters

• Clinical Review of Surgery: Absite Review. 
  Chapter: Urology. 
  Stewart SBEditors: Sapan S. Desai and Danny O. Jacobs.Catalyst, Durham, NCEdition 3rd,2009

Abstracts/Posters

• Patterns of Surveillance Intensity in Kidney Cancer.
  Merrill SB, Schaefer E, Hollenbeak C, American Urologic Association Annual Meeting, Boston, MA, 1/12/2017
• Oncologic Surveillance Following Surgical Resection for Renal Cell Carcinoma: A Novel Risk-based Approach.
  Stewart SB, Thompson RH, Boorjian SA, Psutka S, Lohse CM, Cheville JC, Leibovich BC, Frank I, American Urologic Association Annual Meeting; Society of Urologic Oncology Annual Meeting, Bethesda, MD, 2014; New Orleans, LA, 2015, 1/15/2015
• AUA and NCCN surveillance guidelines for RCC: do they effectively capture recurrences following nephrectomy?
  Stewart SB, Thompson, RH, Psutka S, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Genitourinary Cancers Symposium: American Society of Clinical Oncology (GU ASCO) Annual Meeting, San Francisco, CA, 1/30/2014
• Diabetes Mellitus is Associated with an Increased Risk of Cancer-Specific Mortality among Patients with Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
  Psutka SP, Stewart SB, Lohse C, Tollefson MK, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH, Genitourinary Cancers Symposium: American Society of Clinical Oncology (GU ASCO) Annual Meeting, San Francisco, CA, 1/30/2014
• When can oncologic surveillance following radical cystectomy be safely discontinued?
  Stewart SB, Boorjian SA, Psutka S, Cheville JC, Thapa P, Tarrell R, Tollefson M, Thompson RH, Frank I, American Urologic Association Annual Meeting, Orlando, FL, 1/15/2014
• Standardizing the definition for biochemical recurrence following radical prostatectomy: what PSA cut-point best reflects a durable rise and predicts systemic progress...
  Stewart SB, Boorjian SA, Psutka S, Cheville JC, Thapa P, Tarrell R, Tollefson M, Thompson RH, Frank I, American Urologic Association Annual Meeting, Orlando, FL, 1/15/2014
• EAU and NCCN surveillance guidelines for bladder cancer: do they effectively capture recurrences following cystectomy?
  Stewart SB, Boorjian SA, Psutka S, Cheville JC, Thapa P, Tarrell R, Tollefson M, Thompson RH, Frank I, American Urologic Association Annual Meeting; Genitourinary Cancers Symposium: American Society of Clinical Oncology (GU ASCO) Annual Meeting, San Francisco, CA, 2014; Orlando, FL, 2014, 1/15/2014
• Resource use and costs in the last year of life among medicare beneficiaries who died from prostate cancer versus with prostate cancer between 2000 and 2007.
  Dinan MA, Li Y, Zhang Y, Curtis LH, George DJ, Stewart SB, Reed SD, American Society of Clinical Oncology, Chicago, IL, 1/31/2013
• The TNM lymph node classification for renal cell carcinoma: Does less specific nodal parameters allow similar prognostication?
  Stewart SB, Thompson, RH, Psutka S, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/4/2013
• Diabetes Mellitus is Associated with an Increased Risk of Cancer-Specific Mortality among Patients with Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
  Psutka SP, Stewart SB, Lohse C, Tollefson MK, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/4/2013
• Preoperative risk factors for extensive positive surgical margins following radical prostatectomy.
  Stewart SB, Banez LL, Madden JF, Gerber L, Moul JW, Southeastern Section of the American Urologic Association Annual Meeting, Amelia Island, FL, 1/22/2012
• Cost-effectiveness of chemoprevention with finasteride for prostate cancer varies across subgroups defined by family history and genetic polymorphisms.
  Reed SD, Scales Jr. C, Stewart SB, Sun J, Moul J, Schulman K, Xu J, American Urologic Association Annual Meeting, San Francisco, CA, 1/29/2010
• Risk stratification for prostate cancer using age-specific PSA quartiles.
  Uhlman M, Sun L, Stackhouse D, Stewart SB, Robertson C, Polascik, Albala D, Moul J, American Urologic Association Annual Meeting, San Francisco, CA, 1/29/2010
• The influence of obesity on perioperative parameters in robotic versus open prostatectomy cases at a single center that specializes in both techniques.
  Stewart SB, Tsivian M, Banez L, Gan T, Robertson C, Walther P, Polascik T, Mouraview V, Albala D, Moul J, Southeastern Section of the American Urologic Association Annual Meeting, Miami, FL, 1/11/2010
• Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?
  Stewart SB, Scales Jr. C, Moul JW, Reed SD, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/8/2010
• Utilization trends of a multidisciplinary prostate cancer clinic: initial 5-year experience from The Duke Prostate Center.
  Stewart SB, Banez LL, Xie D, Freedland SJ, Robertson CN, Polascik TJ, Walther PJ, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/8/2010
• Does the multidisciplinary approach improve oncologic outcomes in men undergoing surgical treatment for prostate cancer?
  Stewart SB, Banez LL, Xie D, Freedland SJ, Robertson CN, Polascik TJ, Walther PJ, Koontz BF, Vujaskovic Z, Lee WR, Armstrong AJ, Febbo PG, George DJ, Moul JW, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/8/2010
• Does the extent of positive surgical margins influence biochemical recurrence following radical prostatectomy?—Results from the Duke Prostate Center.
  Stewart SB, Madden JF, Gerber L, Moul JW, Banez LL, Society of Urologic Oncology Annual Meeting, Bethesda, MD, 1/1/2010
• The influence of obesity on perioperative parameters in robotic versus open prostatectomy cases at a single center that specializes in both techniques.
  Stewart SB, Tsivian M, Banez L, Gan T, Robertson C, Walther P, Polascik T, Mouraview V, Albala D, Moul J, Society of Urologic Oncology with World Urological Oncology Federation Annual Meeting, Bethesda, MD, 1/2/2009
• Outcomes of radical prostatectomy in elderly men in the United States.
  Stewart SB, Scales CD, Curtis LH, Schulman KA, Moul JW, Southeastern Section of the American Urologic Association Annual Meeting, San Diego, CA, 1/6/2008
• A phase I study of the novel proteasome inhibitor, PR-171, in patients with hematological malignancies.
  Biehn SE, Voorhees PM, Garcia RA, O’Conner OA, Orlowski RZ, Doris Duke Charitable Foundation Clinical Research Annual Meeting, Duke Farms, Hillsborough, NJ, 1/21/2006
• Extended follow-up of outcome measures and analysis of prognostic factors in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposom...
  Biehn SE, Moore DT, Voorhees PM, Garcia RA, Lehman MJ, Dees EC, Orlowski RZ, American Society of Clinical Oncology Annual Meeting, Atlanta, GA, 1/2/2006
• Extended follow-up of outcome measures and analysis of prognostic factors in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposom...
  Biehn SE, Moore DT, Voorhees PM, Garcia RA, Lehman MJ, Dees EC, Orlowski RZ, ASCO, 1/1/2006
• Induction of organelle biogenesis by Ca2+-ATPase (SERCA1a) expression.
  Biehn SE, Czymmek KJ, Karin NJ, American Society for Cell Biology 42nd Annual International Meeting, Groton, CT, 2002; New Orleans, LA, 2002; San Francisco, CA, 2002, 1/14/2002
• Join now to see all

Lectures

• Complications of Urinary Diversions. 
  Boston, MA - 1/16/2017
• Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival. 
  Boston, MA - 1/12/2017
• Prostate Cancer Screening: The continuing controversy with PSA. 
  Penn State Health St. Joseph Medical Center, Reading, PA - 1/19/2016
• Safety of Active Surveillance in Specific Prostate Cancer Subgroups. 
  Hot Springs, VA - 1/9/2016
• Optimization of RCC Surveillance following Surgery. 
  San Diego, CA - 1/7/2016
• Oncologic Surveillance Following Radical Cystectomy: An Individualized Risk-based Approach. 
  Washington, DC, 2015; San Diego, CA, 2016 - 1/5/2016
• Surveillance strategies in bladder cancer following radical cystectomy: a systematic review and meta-analysis. 
  Chicago, IL, 2014, New Orleans, LA, 2015 - 1/15/2015
• AUA and NCCN surveillance guidelines for RCC: do they effectively capture recurrences following nephrectomy? 
  Orlando, FL - 1/15/2014
• Time trends in perioperative and long-term mortality following cystectomy. 
  Chicago, IL - 1/10/2014
• Does the extent of positive surgical margins influence biochemical recurrence following radical prostatectomy?—Results from the Duke Prostate Center. 
  Amelia Island, FL - 1/22/2012
• Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective? 
  Washington, DC - 1/14/2011
• A True Multi-Disciplinary Clinic for men with newly Diagnosed Prostate Cancer 2004-2009. 
  Orlando, FL - 1/9/2011
• Multidisciplinary Prostate Cancer Approach: The Duke Experience. 
  San Francisco, CA - 1/29/2010
• Are there gains in cost-effectiveness of chemoprevention for prostate cancer when targeting men at higher risk based on family history and genetic markers. 
  Toronto, Canada - 1/24/2010
• Nephrolithiasis and ureteral obstruction: Etiology, Diagnosis and Management. 
  Atlantic Beach, NC - 1/17/2010
• The prevalence of depression in Myasthenia Gravis. 
  Chapel Hill, NC - 1/20/2005
• Join now to see all

Other

• Governor Wolf’s diagnosis brings attention to prostate cancer. 
  Merrill S, National Public Radio—Smart Talk: WITF radio
  1/29/2016
• Induction of organelle biogenesis by Ca2+-ATPase (SERCA1a) expression. 
  Biehn SE, Czymmek KJ, Karin NJ, Senior Thesis
  University of Delaware - 1/1/2002